ABCB1 and Parkinson disease: The current study demonstrated that tetrandrine allowed occurrence of the neuroprotective effect of glutathione probably due to inhibition of P-glycoprotein on 6-hydroxydopamine-lesioned rat models of Parkinson's disease, including the rats undergoing long-term L-dopa treatment.